Anyone tried the new pill form GLP-1?

1mg cagri on top of 4mg reta hitting well early is a good data point for the combination approach. The orforglipron first impression rough on the stomach makes sense - the oral bioavailability challenge often means higher GI burden before reaching therapeutic levels. Different mechanism from reta but the nausea pattern is similar at the start. Did the OP mention what dose they got in the sample?

Stopping Reta two weeks before the filler appointment and finding the hunger stays gone that far out is actually useful data on half-life and residual effect. The OP's Orforglipron experience is interesting for anyone watching the oral GLP-1 space. How has the skin sensitivity been since stopping and did the appointment go as planned?